About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3822781
Allelic
Composition
Hesx1tm3Jpmb/Hesx1tm3Jpmb
Genetic
Background
involves: 129S/SvEv * C57BL/6J * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hesx1tm3Jpmb mutation (0 available); any Hesx1 mutation (14 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• at weaning, less than 5% of animals are homozygous mutants instead of expected 25%

vision/eye
• all surviving homozygotes display eye defects, typically bilateral microphthalmia or anophthalmia
• all surviving homozygotes display eye defects, typically bilateral microphthalmia or anophthalmia

endocrine/exocrine glands
• pituitary defects are fully penetrant
• some have an enlarged, bifurcated anterior pituitary, often connected to the oral cavity
• this is the type I phenotype, which is the pituitary phenotype observed in some (>50%) animals
• in some embryos at 12.5 dpc, development of Rathke's pouch is delayed (by about 1 day); pouch remains embedded within oral ectoderm and appears rostrally expanded
• this is the type II phenotype, always associated with a lack of anterior forebrain tissue
• type II phenotype is associated with a delay in Rathke's pouch development, impaired basisphenoid cartilage development, and ectopic pituitary in the nasopharynx
• in embryos displaying severe craniofacial defects at 15.5-17.5 dpc, a defined pituitary gland can not be recognized at its normal location

nervous system
• embryos at 17.5 dpc and surviving adult mutants exhibit abnormal development of telencephalic commissural tracts
• agenesis or hypoplasia is observed in embryos at 17.5 dpc and surviving adults (78%)
• forebrain defects are observed
• pituitary defects are fully penetrant
• some have an enlarged, bifurcated anterior pituitary, often connected to the oral cavity
• this is the type I phenotype, which is the pituitary phenotype observed in some (>50%) animals
• in some embryos at 12.5 dpc, development of Rathke's pouch is delayed (by about 1 day); pouch remains embedded within oral ectoderm and appears rostrally expanded
• this is the type II phenotype, always associated with a lack of anterior forebrain tissue
• type II phenotype is associated with a delay in Rathke's pouch development, impaired basisphenoid cartilage development, and ectopic pituitary in the nasopharynx
• in embryos displaying severe craniofacial defects at 15.5-17.5 dpc, a defined pituitary gland can not be recognized at its normal location
• reduced anterior forebrain tissue is found associated with Rathke's pouch abnormalities
• significant reduction in telencephalic tissue is detected in severely affected embryos
• telencephalic vesicles are normal in some embryos but are reduced in other embryos
• agenesis or hypoplasia is observed in embryos at 17.5 dpc and surviving adults (78%)

craniofacial
• frontonasal mass is defective or absent in >25% of embryos examined at 12.5-17.5 dpc
• frontonasal mass is defective or absent in >25% of embryos examined at 12.5-17.5 dpc

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
septooptic dysplasia DOID:0060857 OMIM:182230
J:142649


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory